다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Marker Therapeutics (delisted) (TPIV)
Marker Therapeutics (delisted) (TPIV) 뉴스

TPIV

TapImmune, Inc. (TPIV)

Marker Therapeutics (delisted)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:TPIV

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2018/10/20	06:10	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/20	05:55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/20	05:53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/20	05:34	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/20	05:33	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/20	05:31	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05:54	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05:54	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05:54	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05:54	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05:53	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05:52	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05:52	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05:51	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05:51	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05:51	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05:50	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05:50	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05:49	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/18	05:02	Edgar (US Regulatory)	Amended Securities Registration (section 12(b)) (8-a12b/a)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/18	05:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/18	00:45	PR Newswire (US)	TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/17	21:56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/17	21:54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/17	21:52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/17	21:49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/17	21:47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/11	05:53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/10	19:30	PR Newswire (US)	TapImmune's HER2/neu-Targeted Breast Cancer Vaccine to be Studied in a Large Phase 2 Immunotherapy Combination Study Funded b...	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/09/26	06:05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)

검색 관련기사 보기:NASDAQ:TPIV

1 2 3 4 5 6 7 8 9 10 다음 >>

Energy Select Sector SPDR

JP Morgan Chase

American Express

Health Care Select Sector

US Dollar vs Sterling

US Dollar vs Euro

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관